(Size: 50 µg)
Click on the image to see the image legend
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Mammalian cells.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
The L452R mutation is present in the B.1.429/B.1.427 (CAL.20C/Epsilon) variant first identified in California, USA.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (L452R Mutation)
||Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (L452R Mutation)
||Optimal dilutions/concentrations should be determined by the end user.
||> 90% (SDS-PAGE)
||Reconstitute in ddH2O to a concentration of 1 mg/ml.
||Store between -20 °C and -80 °C. Avoid repeated freeze/thaw cycles.
||Observed MW: 35 kDa
||C-terminal His tag
||Prior to lyophilization: PBS, pH 7.5.
||Shipped within 5-10 working days.
||This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.